Japanese dentists are now paying far more for palladium, a rare earth metal that is an essential ingredient for making dental crowns, due to economic sanctions imposed against Russia due to its Ukraine invasion.
Russia accounts for about 40 percent of the global palladium production.
The price of the alloy containing palladium has skyrocketed over fears of supply chain disruptions as a result of the sanctions.
In mid-December, the purchase price of palladium per 30 grams was 77,770 yen ($653), including tax. As of March 9, the price of palladium per 30 grams had surged to 125,400 yen.
According to Toshiaki Tanaka, a director of the prefectural association of doctors and dentists in Kanagawa, the dentists are not being reimbursed for their additional costs under the national medical insurance system.
Dentists prefer an alloy of gold, silver, and palladium in fashioning a dental crown due to the alloy’s strength and durability when patients want treatment covered by national health insurance.
Dental crowns that do not contain palladium are not as strong and tend to discolor over time.
Medical institutions do not get reimbursed in medical fees due to a rise in materials when they give treatment covered by the national health program because the fees are fixed.
The current material fee for the alloy using palladium is 88,530 yen per 30 grams even after the purchase price increased by 30,000 yen.
Tanaka expressed concern that the increased cost may prompt some people to put off going to a dentist, even though they are in desperate need of treatment, and called on the government to take emergency steps to resolve the problem. He suggested that a provision like a government subsidy to rein in gasoline prices be made available for palladium.


Japan Finance Minister Defends PM Takaichi’s Remarks on Weak Yen Benefits
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
RBA Raises Interest Rates by 25 Basis Points as Inflation Pressures Persist
Philippines Manufacturing PMI Hits Nine-Month High Despite Weak Confidence Outlook
Trump Announces U.S.–India Trade Deal Cutting Tariffs, Boosting Markets and Energy Ties
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
UK Employers Plan Moderate Pay Rises as Inflation Pressures Ease but Persist
EU Recovery Fund Faces Bottlenecks Despite Driving Digital and Green Projects
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Taiwan Urges Stronger Trade Ties With Fellow Democracies, Rejects Economic Dependence on China
Oil Prices Steady as Markets Weigh U.S.-Iran Talks, Dollar Strength Caps Gains 



